Novartis.com | Contact Us | Help | Site Map | Stay Connected | Large Text Version Regular Text Version

Home

LATEST NEWS FROM NOVARTIS ONCOLOGY

01-Jul-2010

Phase III study shows Novartis drug Afinitor® more than doubles time without tumor growth in advanced pancreatic NET patients

18-Jun-2010

FDA approves Tasigna® for newly diagnosed chronic myeloid leukemia patients, data demonstrate major advance over Glivec®

05-Jun-2010

Study at ASCO shows Novartis drug Afinitor® first to shrink SEGA brain tumors in children and adults with tuberous sclerosis

Visit our newsroom


View Videos of Novartis Patient Stories

LaDonna Lopossa	Carol Lundin	Suzan M.	John Ivey


learn more ›	learn more ›	learn more ›	learn more ›


learn more ›	learn more ›	learn more ›

SEARCH OUR WEBSITES

ABOUT NOVARTIS ONCOLOGY

Learn More About Novartis Oncology

We deliver a broad range of innovative therapies, cancer resources and oncology drugs to improve and extend the lives of cancer patients.

Learn more about Novartis Oncology

Use of this website is governed by our Terms of Use and Privacy Policy. © Novartis AG

Disclaimer: This site is intended to provide information to audiences outside the United States. Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local Novartis company for local prescribing and any other information you may be interested in.